Haematology News/Publications

2005

• Jayandharan GR, Shaji R.V, Baidya S, Nair SC, Chandy M, Srivastava. Molecular characterization of factor IX gene mutations in 53 patients with haemophilia B in India. Thromb Haemost 2005; 94: 883-886.
• Jayandharan G, Shaji RV, Baidya S, Nair SC, Chandy M, Srivastava, A. Identification of factor VIII gene mutations in 101 patients with haemophilia A: mutation analysis by inversion screening and multiplex PCR and CSGE and molecular modelling of 10 novel missense substitutions. Haemophilia2005; 11: 481-491.
• Jayandharan G, Viswabandya A, Baidya S, Nair SC, Shaji RV, Chandy M, Srivastava A. Molecular genetics of hereditary prothrombin deficiency in Indian patients: identification of a novel Ala362-->Thr (Prothrombin Vellore 1) mutation. J Thromb Haemost 2005; 3: 1482-1487.
• Jayandharan G, Shaji RV, Nair SC, Chandy M, Srivastava A. Novel missense mutations in two patients with factor XI deficiency (Val271Leu and Tyr351Ser) and one patient with combined factor XI and factor IX deficiency (Phe349Val).  J Thromb Haemost 2005; 3: 808–811
• Chandy M, Balasubramanian P, Ramachandran SV, Mathews V, George B, Dennison D,Krishnamoorthy R, Srivastava A. Randomized trial of two different conditioning regimens for bone marrow transplantation in thalassemia--the role of busulfan pharmacokinetics in determining outcome. Bone Marrow Transplant. 2005 Nov;36(10):839-845.
• 6. Poonkuzhali B, Shaji RV, Salamun DE, George B, Srivastava A, Chandy M. Cytochrome P4501A1 and glutathione S transferase gene polymorphisms in patients with aplastic anemia in India. Acta Haematol. 2005;114(3):127-132.
• George B, Poonkuzhali B, Srivastava VM, Chandy M, Srivastava A. Hematological and molecular remission with combination chemotherapy in a patient with PLZF-RARalpha acute promyelocytic leukemia (APML). Ann Hematol. 2005 Jun;84(6):406-408.
• Srivastava A, Rodeghiero F. Epidemiology of von Willebrand disease in developing countries. Semin Thromb Hemost. 2005;31(5):569-576.
• Mathews V, Viswabandya A, Baidya S, George B, Nair S, Chandy M, Srivastava A.  Surgery for hemophilia in developing countries. Semin Thromb Hemost. 2005;31(5):538-543
10. Srivastava A, You SK, Ayob Y, Chuansumrit A, de Bosch N, Perez Bianco R, Ala F. Hemophilia treatment in developing countries: products and protocols. Semin Thromb Hemost. 2005;31(5):495-500.
• G. Jayandharan, R.V. Shaji, S.C. Nair, M. Chandy and A. Srivastava. Novel missense mutations in two patients with factor XI deficiency (Val271Leu and Tyr351Ser) and one patient with combined factor XI and factor IX deficiency       (Phe349Val). Thromb Haemost 2005;94: 808-811
• Jayandharan GJ, Shaji RV, Baidya S, Nair SC, Chandy M, Srivastava A. Molecular characterization of factor IX gene mutations in 53 patients with haemophilia B in India.  Thromb Haemost 2005;94:883-886.
• Poonnoose PM, Manigandan C, Thomas R, Shyamkumar NK, Kavitha ML, Bhattacharji S, Srivastava A. Functional Independence Score in Haemophilia: a new performance-based instrument to measure disability. Haemophilia. 2005;11(6):598-602.
• Poonkuzhali B, Shaji RV, Salamun DE, George B, Srivastava A, Chandy M. Cytochrome P4501A1 and glutathione S transferase gene polymorphisms in patients with aplastic anemia in India. Acta Haematol. 2005;114(3):127-132.
• Chandy M, Balasubramanian P, Shaji R V, Mathews V, George B, Dennison D, Krishnamoorthy R, Srivastava A. Randomized trial of two different conditioning regimes for BMT in thalassaemia – The role of busulfan pharmacokinetics in determining outcome. Bone Marrow Transplant. 2005;36(10):839-845.
• Jayandharan G, Shaji RV, Baidya S, Nair SC, Chandy M, Srivastava A. Identification of factor VIII gene mutations in 101 patients with haemophilia A: mutation analysis by inversion screening and multiplex PCR and CSGE and molecular modelling of 10 novel missense substitutions. Haemophilia. 2005; 11(5):481-491.
• Edison ES, Shaji RV, Srivastava A, Chandy M. Compound heterozygosity for Hb E and Hb Lepore-Hollandia in India; first report and potential diagnostic pitfalls. Hemoglobin. 2005;29:221-224
• Damodar S, George B, Mammen J, Mathews V, Srivastava A, Chandy M. Pre-transplant reduction of isohaemagglutinin titres by donor group plasma infusion does not reduce the incidence of pure red cell aplasia in major ABO-mismatched transplants. Bone Marrow Transplant. 2005 Aug;36(3):233-235.
• Srivastava A. Gene therapy for hemophilia.  J Thromb Haemost 2005; 3:1313
• Jayandharan G, Shaji RV, Nair SC, Chandy M, Srivastava A. Novel missense mutations in two patients with factor XI deficiency (Val271Leu and Tyr351Ser) and one patient with combined factor XI and factor IX deficiency (Phe349Val).  J Thromb Haemost 2005; 3: 808–811.
• Jayandharan G, Viswabandya A, Baidya S, Nair SC, Shaji RV, Chandy M, Srivastava A. Molecular genetics of hereditary prothrombin deficiency in Indian patients: identification of a novel Ala362 --> Thr (Prothrombin Vellore 1) mutation. J Thromb Haemost 2005; 3(7): 1446-1453.
• Edison ES, Shaji RV, Srivastava A, Chandy M. Hyperbilirubinemia in homozygous HbE disease is associated with the UGT1A1 gene polymorphism. Hemoglobin. 2005;29:189-195 PubMed PMID: 16114182.
• Edison ES, Shaji RV, Devi SG, Kumar SS, Srivastava A, Chandy M. Hb Showa-Yakushiji [beta110(G12)Leu-->Pro] in four unrelated patients from west Bengal Hemoglobin. 2005;29:19-25.
• F. Rodeghiero, G. Castaman, A. Tosetto, J. Batlle, F.Baudo, A. Cappelletti, P. Casana, S.N. De Bosch, J C J Eikenboom, A.B. Federici, S. Lethagen, S.Linariss and A. Srivastava.  The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study. J Thromb Haemost. 2005; 3: 2619-2626
• E.J.R. Nelson, J.LI, W.B. Mitchell, M. Chandy, A.Srivastava and B.S. Coller. Three novel b-propeller mutations causing Glanzmann thrombasthenia result in production of normally stable pro-aIIb,but variably impaired progression of pro-aIIbb3 from endoplasmic reticulum to Golgi. J Thromb Haemost. 2005; Jul; 3: 2773-2783.
• Srivastava A. von Willebrand disease in the developing world. Semin Hematol. 2005; 42:36-41
• George B, Mathews V, Shaji RV, Srivastava V, Srivastava A, Chandy M. Fludarabine-based conditioning for allogeneic stem cell transplantation for multiply transfused patients with Fanconi's anemia. Bone Marrow Transplant. 2005; 35(4):341-343.      
• George B, Poonkuzhali B, Srivastava VM, Chandy M, Srivastava A. Hematological and molecular remission with combination chemotherapy in a patient with PLZF-RARalpha acute promyelocytic leukemia (APML). Ann Hematol. 2005;84:406-408.
• Devine SM, Brown RA, Mathews V, Trinkaus K, Khoury H, Adkins D, Vij R, Sempek D, Graubert T, Tomasson M, Goodnough LT, DiPersio JF. Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF alone. Bone Marrow Transplant. 2005;36:531-538.
• Damodar S, Viswabandya A, George B, Mathews V, Chandy M, Srivastava A. Dapsone for chronic idiopathic thrombocytopenic purpura in children and adults--a report on 90 patients. Eur J Haematol. 2005;75:328-331
• Damodar S, George B, Mammen J, Mathews V, Srivastava A, Chandy M. Pre-transplant reduction of isohaemagglutinin titres by donor group plasma infusion does not reduce the incidence of pure red cell aplasia in major ABO-mismatched transplants. Bone Marrow Transplant. 2005;36:233-235.

<< Back to Archives